Vernalis buys intranasal opioid company
UK biotechnology company Ionix Pharmaceuticals is gearing up for acquisition by Vernalis in a share-based deal valuing Ionix at around £12.5 million (€18.2m).
UK biotechnology company Ionix Pharmaceuticals is gearing up for acquisition by Vernalis in a share-based deal valuing Ionix at around £12.5 million (€18.2m).
Hamilton launches two new products, which are set to aid the facilitation of automation in laboratories, placing tedious and time-consuming processes in the hands of cutting edge and cost-effective technology for automation.
A recent study designed to assess biopharmaceutical innovation in the member states of the Organisation for Economic Cooperation and Development has found that, in terms of innovation and biotechnology industry development, Belgium is the best...